You are here:
NICE
NICE Guidance
Conditions and diseases
Sleep and sleep conditions
Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia
Technology appraisal guidance
Reference number:
TA77
Published:
28 April 2004
Guidance
Tools and resources
Information for the public
History
Download guidance (PDF)
Overview
1 Guidance
2 Clinical need and practice
3 The technologies
4 Evidence and interpretation
5 Recommendations for further research
6 Implications for the NHS
7 Implementation and audit
8 Related guidance
Appendix A. Appraisal Committee members and NICE project team
Appendix B. Sources of evidence considered by the Committee
Appendix C. Detail on criteria for audit of the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia
Update information
8 Related guidance
8.1
There is no specific related NICE guidance for the management of insomnia.
Next page
Appendix A. Appraisal Committee members and NICE project team
Previous page
7 Implementation and audit